Abstract:
A plasmid consists essentially of a small pCMV4 expression vector including a coding sequence of human alpha-1 antitrypsin incorporated therein. The present invention further provides a method for delivering the gene to a patient, the mechanism including a liposome including the expression plasmid incorporated therein, the plasmid being capable of expression of the gene extrachromosomally in the cells of a target tissue and being unincorporable into the chromosome of the cells of the target tissue. The present invention further provides a primer for inserting the coding sequence of the protein into the expression vector. Finally, the present invention provides a method of treatment for deficiency of a gene product in cells of a target tissue by using the novel liposome.
Abstract:
The present invention provides novel methods for gene delivery and expression in areas that are currently inaccessible through the use of conventional direct protein delivery techniques. In particular, the methods and related products provided herein can be used in the treatment of α1 antitrypsin (AAT) related disorders such as respiratory syncytial virus (RSV) infection.